{{Rsnum
|rsid=886144
|Gene=SV2B
|Chromosome=15
|position=91174122
|Orientation=minus
|GMAF=0.2718
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SV2B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.7 | 38.4 | 50.9
| HCB | 2.2 | 8.0 | 89.8
| JPT | 0.0 | 8.0 | 92.0
| YRI | 26.5 | 49.0 | 24.5
| ASW | 14.0 | 50.9 | 35.1
| CHB | 2.2 | 8.0 | 89.8
| CHD | 0.0 | 14.7 | 85.3
| GIH | 12.9 | 35.6 | 51.5
| LWK | 19.1 | 54.5 | 26.4
| MEX | 3.4 | 29.3 | 67.2
| MKK | 21.2 | 44.2 | 34.6
| TSI | 17.6 | 44.1 | 38.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=2E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs886144
|Name_s=
|Gene_s=SV2B
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 15q26.1; Reported Gene(s): SV2B; Risk Allele: rs886144-?); (p-value= 0.0000002).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740309
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs886144
|overall_frequency_n=41
|overall_frequency_d=128
|overall_frequency=0.320312
|n_genomes=32
|n_genomes_annotated=0
|n_haplomes=36
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}